financetom
Business
financetom
/
Business
/
Tesla Q3 Adjusted Earnings Fall, Revenue Rises
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tesla Q3 Adjusted Earnings Fall, Revenue Rises
Oct 22, 2025 1:21 PM

04:10 PM EDT, 10/22/2025 (MT Newswires) -- Tesla (TSLA) reported Q3 adjusted earnings late Wednesday of $0.50 per diluted share, down from $0.72 a year earlier.

Analysts polled by FactSet expected $0.56.

Revenue for the quarter was $28.10 billion, up from $25.18 billion a year earlier.

Analysts surveyed by FactSet expected $26.54 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Street Color: Barrick Gold CEO Mark Bristow's Arrest Warrant Reportedly Issued by Mali
--Street Color: Barrick Gold CEO Mark Bristow's Arrest Warrant Reportedly Issued by Mali
Dec 5, 2024
12:03 PM EST, 12/05/2024 (MT Newswires) -- Price: 16.96, Change: -0.41, Percent Change: -2.38 ...
Explainer-What is known about the shooting of UnitedHealth executive Brian Thompson 
Explainer-What is known about the shooting of UnitedHealth executive Brian Thompson 
Dec 5, 2024
(Reuters) - New York City police were still searching for the man who killed UnitedHealth ( UNH ) executive Brian Thompson outside a Midtown Manhattan hotel early Wednesday. Here is what is known about the incident, Thompson, and the suspect:     WHAT HAPPENED? HOW DID THE SUSPECT ESCAPE? At about 6:45 a.m. ET on Wednesday, Thompson was walking from his hotel...
Mind Medicine Gets UK's Innovation Passport Designation for Investigational Anxiety Disorder Treatment
Mind Medicine Gets UK's Innovation Passport Designation for Investigational Anxiety Disorder Treatment
Dec 5, 2024
12:00 PM EST, 12/05/2024 (MT Newswires) -- Mind Medicine (MNMD) said Thursday the UK's Medicines and Healthcare Products Regulatory Agency granted an Innovation Passport designation for its MM120 orally disintegrated table, which is currently in clinical development for the treatment of generalized anxiety disorder. The designation allows access to tools to support the design, development, and approvals process in the...
CG Oncology Reports 74.5% Complete Response in Study of Bladder Cancer Candidate
CG Oncology Reports 74.5% Complete Response in Study of Bladder Cancer Candidate
Dec 5, 2024
12:01 PM EST, 12/05/2024 (MT Newswires) -- CG Oncology ( CGON ) said Thursday that topline data from its phase 3 trial in patients with high-risk non-muscle invasive bladder cancer, unresponsive to Bacillus Calmette Guerin, showed 74.5% achieved a complete response at any time following treatment with cretostimogene as a single agent. No grade 3 or higher treatment-related adverse events...
Copyright 2023-2026 - www.financetom.com All Rights Reserved